These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 37973606)

  • 21. SARS-CoV-2 Vaccination and Myocarditis in a Nordic Cohort Study of 23 Million Residents.
    Karlstad Ø; Hovi P; Husby A; Härkänen T; Selmer RM; Pihlström N; Hansen JV; Nohynek H; Gunnes N; Sundström A; Wohlfahrt J; Nieminen TA; Grünewald M; Gulseth HL; Hviid A; Ljung R
    JAMA Cardiol; 2022 Jun; 7(6):600-612. PubMed ID: 35442390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of COVID-19 Vaccination During Pregnancy With Incidence of SARS-CoV-2 Infection in Infants.
    Carlsen EØ; Magnus MC; Oakley L; Fell DB; Greve-Isdahl M; Kinge JM; Håberg SE
    JAMA Intern Med; 2022 Aug; 182(8):825-831. PubMed ID: 35648413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. COVID-19 Booster Vaccination in Early Pregnancy and Surveillance for Spontaneous Abortion.
    Kharbanda EO; Haapala J; Lipkind HS; DeSilva MB; Zhu J; Vesco KK; Daley MF; Donahue JG; Getahun D; Hambidge SJ; Irving SA; Klein NP; Nelson JC; Weintraub ES; Williams JTB; Vazquez-Benitez G
    JAMA Netw Open; 2023 May; 6(5):e2314350. PubMed ID: 37204791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Receipt of COVID-19 Vaccine During Pregnancy and Preterm or Small-for-Gestational-Age at Birth - Eight Integrated Health Care Organizations, United States, December 15, 2020-July 22, 2021.
    Lipkind HS; Vazquez-Benitez G; DeSilva M; Vesco KK; Ackerman-Banks C; Zhu J; Boyce TG; Daley MF; Fuller CC; Getahun D; Irving SA; Jackson LA; Williams JTB; Zerbo O; McNeil MM; Olson CK; Weintraub E; Kharbanda EO
    MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(1):26-30. PubMed ID: 34990445
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence of diabetes following COVID-19 vaccination and SARS-CoV-2 infection in Hong Kong: A population-based cohort study.
    Xiong X; Lui DTW; Chung MSH; Au ICH; Lai FTT; Wan EYF; Chui CSL; Li X; Cheng FWT; Cheung CL; Chan EWY; Lee CH; Woo YC; Tan KCB; Wong CKH; Wong ICK
    PLoS Med; 2023 Jul; 20(7):e1004274. PubMed ID: 37486927
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data.
    Haas EJ; Angulo FJ; McLaughlin JM; Anis E; Singer SR; Khan F; Brooks N; Smaja M; Mircus G; Pan K; Southern J; Swerdlow DL; Jodar L; Levy Y; Alroy-Preis S
    Lancet; 2021 May; 397(10287):1819-1829. PubMed ID: 33964222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SARS-CoV-2 vaccine uptake and reasons for hesitancy among Canadian pregnant people: a prospective cohort study.
    Gorgui J; Atallah A; Boucoiran I; Gomez YH; Bérard A;
    CMAJ Open; 2022; 10(4):E1034-E1043. PubMed ID: 36735245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reductions in stillbirths and preterm birth in COVID-19-vaccinated women: a multicenter cohort study of vaccination uptake and perinatal outcomes.
    Hui L; Marzan MB; Rolnik DL; Potenza S; Pritchard N; Said JM; Palmer KR; Whitehead CL; Sheehan PM; Ford J; Mol BW; Walker SP
    Am J Obstet Gynecol; 2023 May; 228(5):585.e1-585.e16. PubMed ID: 36336084
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk of SARS-CoV-2 infection following initial COVID-19 vaccination: Population-based cohort study.
    Tadrous M; Chung H; Men S; Chu C; Campbell T; Juurlink DN; Kwong JC; Paterson JM; Gomes T
    PLoS One; 2022; 17(10):e0273903. PubMed ID: 36264950
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of Maternal and Neonatal Antibody Levels After COVID-19 Vaccination vs SARS-CoV-2 Infection.
    Flannery DD; Gouma S; Dhudasia MB; Mukhopadhyay S; Pfeifer MR; Woodford EC; Briker SM; Triebwasser JE; Gerber JS; Morris JS; Weirick ME; McAllister CM; Hensley SE; Puopolo KM
    JAMA Netw Open; 2022 Nov; 5(11):e2240993. PubMed ID: 36350652
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety of third SARS-CoV-2 vaccine (booster dose) during pregnancy.
    Dick A; Rosenbloom JI; Karavani G; Gutman-Ido E; Lessans N; Chill HH
    Am J Obstet Gynecol MFM; 2022 Jul; 4(4):100637. PubMed ID: 35398583
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Short-term outcome of pregnant women vaccinated with BNT162b2 mRNA COVID-19 vaccine.
    Bookstein Peretz S; Regev N; Novick L; Nachshol M; Goffer E; Ben-David A; Asraf K; Doolman R; Levin EG; Regev Yochay G; Yinon Y
    Ultrasound Obstet Gynecol; 2021 Sep; 58(3):450-456. PubMed ID: 34198360
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of COVID-19 Vaccination With SARS-CoV-2 Infection in Patients With Cancer: A US Nationwide Veterans Affairs Study.
    Wu JT; La J; Branch-Elliman W; Huhmann LB; Han SS; Parmigiani G; Tuck DP; Brophy MT; Do NV; Lin AY; Munshi NC; Fillmore NR
    JAMA Oncol; 2022 Feb; 8(2):281-286. PubMed ID: 34854921
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A population-based matched cohort study of major congenital anomalies following COVID-19 vaccination and SARS-CoV-2 infection.
    Calvert C; Carruthers J; Denny C; Donaghy J; Hopcroft LEM; Hopkins L; Goulding A; Lindsay L; McLaughlin T; Moore E; Taylor B; Loane M; Dolk H; Morris J; Auyeung B; Bhaskaran K; Gibbons CL; Katikireddi SV; O'Leary M; McAllister D; Shi T; Simpson CR; Robertson C; Sheikh A; Stock SJ; Wood R
    Nat Commun; 2023 Jan; 14(1):107. PubMed ID: 36609574
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Maternal, fetal and neonatal outcomes among pregnant women receiving COVID-19 vaccination: The preg-co-vax study.
    Mascolo A; di Mauro G; Fraenza F; Gaio M; Zinzi A; Pentella C; Rossi F; Capuano A; Sportiello L
    Front Immunol; 2022; 13():965171. PubMed ID: 36263025
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association Between Time Interval from COVID-19 Vaccination to In Vitro Fertilization and Pregnancy Rate After Fresh Embryo Transfer.
    Shi W; Wang M; Xue X; Li N; Chen L; Shi J
    JAMA Netw Open; 2022 Oct; 5(10):e2236609. PubMed ID: 36239937
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SARS-CoV-2 vaccine effectiveness in preventing confirmed infection in pregnant women.
    Butt AA; Chemaitelly H; Al Khal A; Coyle PV; Saleh H; Kaleeckal AH; Latif AN; Bertollini R; Abou-Samra AB; Abu-Raddad LJ
    J Clin Invest; 2021 Dec; 131(23):. PubMed ID: 34618693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety of SARS-CoV-2 vaccination during pregnancy- obstetric outcomes from a large cohort study.
    Dick A; Rosenbloom JI; Gutman-Ido E; Lessans N; Cahen-Peretz A; Chill HH
    BMC Pregnancy Childbirth; 2022 Feb; 22(1):166. PubMed ID: 35227233
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness and Safety of COVID-19 Vaccination During Preconceptional and Preclinical Pregnancy Period: A National Population Study.
    Gwak E; Kim T; Shin JY; Choi NK; Han S; Lee JY; Choe YJ; Choe SA
    J Korean Med Sci; 2023 Oct; 38(41):e314. PubMed ID: 37873626
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Miscarriage after SARS-CoV-2 vaccination: A request to report more details of the regression models and analyses.
    Levi R; Schurr E
    BJOG; 2024 Aug; 131(9):1322. PubMed ID: 38247342
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.